FOR IMMEDIATE RELEASE | Exhibit 99.1 |
• | Reported sales increased 3% compared with the prior year. In local currency, sales increased 4% in the quarter as currency reduced sales growth by 1%. |
• | Net earnings per diluted share as reported (EPS) were $7.84, compared with $7.11 in the prior-year period. Adjusted EPS was $7.78, an increase of 14% over the prior-year amount of $6.85. Adjusted EPS is a non-GAAP measure, and we have included a reconciliation to EPS on the last page of the attached schedules. |
METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS (amounts in thousands except share data) (unaudited) | |||||||||||||||
Three months ended | Three months ended | ||||||||||||||
December 31, 2019 | % of sales | December 31, 2018 | % of sales | ||||||||||||
Net sales | $ | 843,969 | (a) | 100.0 | $ | 817,923 | 100.0 | ||||||||
Cost of sales | 345,672 | 41.0 | 340,357 | 41.6 | |||||||||||
Gross profit | 498,297 | 59.0 | 477,566 | 58.4 | |||||||||||
Research and development | 35,299 | 4.2 | 36,205 | 4.4 | |||||||||||
Selling, general and administrative | 206,717 | 24.5 | 201,653 | 24.7 | |||||||||||
Amortization | 12,813 | 1.5 | 11,963 | 1.5 | |||||||||||
Interest expense | 9,635 | 1.1 | 8,840 | 1.1 | |||||||||||
Restructuring charges | 4,614 | 0.5 | 4,464 | 0.5 | |||||||||||
Other charges (income), net | (1,924 | ) | (0.3 | ) | (16,013 | ) | (c) | (2.0 | ) | ||||||
Earnings before taxes | 231,143 | 27.3 | 230,454 | 28.2 | |||||||||||
Provision for taxes | 38,394 | (b) | 4.5 | 49,268 | (b) | 6.0 | |||||||||
Net earnings | $ | 192,749 | 22.8 | $ | 181,186 | 22.2 | |||||||||
Basic earnings per common share: | |||||||||||||||
Net earnings | $ | 7.95 | $ | 7.25 | |||||||||||
Weighted average number of common shares | 24,241,383 | 249,975,303 | |||||||||||||
Diluted earnings per common share: | |||||||||||||||
Net earnings | $ | 7.84 | $ | 7.11 | |||||||||||
Weighted average number of common and common equivalent shares | 24,599,702 | 25,490,270 | |||||||||||||
Note: | |||||||||||||||
(a) | Local currency sales increased 4% as compared to the same period in 2018. | ||||||||||||||
(b) | Provision for taxes includes a non-cash deferred net benefit of $15.8 million for the three months ended December 31, 2019 related to the enactment of Swiss tax reform and a charge of $3.6 million for the three months ended December 31, 2018 for the enactment of the U.S. Tax Cuts and Jobs Act. | ||||||||||||||
(c) | Other charges (income), net includes a one-time gain of $18.7 million relating to the Biotix acquisition contingent consideration and a one-time legal charge of $3.0 million for the three months ended December 31, 2018. | ||||||||||||||
RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT | |||||||||||||||
Three months ended | Three months ended | ||||||||||||||
December 31, 2019 | % of sales | December 31, 2018 | % of sales | ||||||||||||
Earnings before taxes | $ | 231,143 | $ | 230,454 | |||||||||||
Amortization | 12,813 | 11,963 | |||||||||||||
Interest expense | 9,635 | 8,840 | |||||||||||||
Restructuring charges | 4,614 | 4,464 | |||||||||||||
Other charges (income), net | (1,924 | ) | (16,013 | ) | |||||||||||
Adjusted operating profit | $ | 256,281 | (d) | 30.4 | $ | 239,708 | 29.3 | ||||||||
Note: | |||||||||||||||
(d) | Adjusted operating profit increased 7% as compared to the same period in 2018. |
METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS (amounts in thousands except share data) (unaudited) | |||||||||||||||
Twelve months ended | Twelve months ended | ||||||||||||||
December 31, 2019 | % of sales | December 31, 2018 | % of sales | ||||||||||||
Net sales | $ | 3,008,652 | (a) | 100.0 | $ | 2,935,586 | 100.0 | ||||||||
Cost of sales | 1,267,441 | 42.1 | 1,251,208 | 42.6 | |||||||||||
Gross profit | 1,741,211 | 57.9 | 1,684,378 | 57.4 | |||||||||||
Research and development | 143,950 | 4.8 | 141,071 | 4.8 | |||||||||||
Selling, general and administrative | 819,183 | 27.2 | 812,802 | 27.7 | |||||||||||
Amortization | 49,690 | 1.7 | 47,524 | 1.6 | |||||||||||
Interest expense | 37,411 | 1.2 | 34,511 | 1.2 | |||||||||||
Restructuring charges | 15,760 | 0.5 | 18,420 | 0.6 | |||||||||||
Other charges (income), net | (6,177 | ) | (0.3 | ) | (21,808 | ) | (c) | (0.7 | ) | ||||||
Earnings before taxes | 681,394 | 22.6 | 651,858 | 22.2 | |||||||||||
Provision for taxes | 120,285 | (b) | 4.0 | 139,247 | (b) | 4.7 | |||||||||
Net earnings | $ | 561,109 | 18.6 | $ | 512,611 | 17.5 | |||||||||
Basic earnings per common share: | |||||||||||||||
Net earnings | $ | 22.84 | $ | 20.33 | |||||||||||
Weighted average number of common shares | 24,567,609 | 25,215,674 | |||||||||||||
Diluted earnings per common share: | |||||||||||||||
Net earnings | $ | 22.47 | $ | 19.88 | |||||||||||
Weighted average number of common and common equivalent shares | 24,974,457 | 25,781,324 | |||||||||||||
Note: | |||||||||||||||
(a) | Local currency sales increased 5% as compared to the same period in 2018. | ||||||||||||||
(b) | Provision for taxes includes a non-cash deferred net benefit of $15.8 million for twelve months ended December 31, 2019 related to the enactment of Swiss tax reform and a charge of $3.6 million for the twelve months ended December 31, 2018 for the enactment of the U.S. Tax Cuts and Jobs Act. | ||||||||||||||
(c) | Other charges (income), net includes a one-time gain of $18.7 million relating to the Biotix acquisition contingent consideration and a one-time legal charge of $3.0 million for the twelve months ended December 31, 2018. | ||||||||||||||
RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT | |||||||||||||||
Twelve months ended | Twelve months ended | ||||||||||||||
December 31, 2019 | % of sales | December 31, 2018 | % of sales | ||||||||||||
Earnings before taxes | $ | 681,394 | $ | 651,858 | |||||||||||
Amortization | 49,690 | 47,524 | |||||||||||||
Interest expense | 37,411 | 34,511 | |||||||||||||
Restructuring charges | 15,760 | 18,420 | |||||||||||||
Other charges (income), net | (6,177 | ) | (21,808 | ) | |||||||||||
Adjusted operating profit | $ | 778,078 | (d) | 25.9 | $ | 730,505 | 24.9 | ||||||||
Note: | |||||||||||||||
(d) | Adjusted operating profit increased 7% as compared to the same period in 2018. |
METTLER-TOLEDO INTERNATIONAL INC. CONDENSED CONSOLIDATED BALANCE SHEETS (amounts in thousands) (unaudited) | ||||||||
December 31, 2019 | December 31, 2018 | |||||||
Cash and cash equivalents | $ | 207,785 | $ | 178,110 | ||||
Accounts receivable, net | 566,256 | 535,528 | ||||||
Inventories | 274,285 | 268,821 | ||||||
Other current assets and prepaid expenses | 61,321 | 63,401 | ||||||
Total current assets | 1,109,647 | 1,045,860 | ||||||
Property, plant and equipment, net | 748,657 | 717,526 | ||||||
Goodwill and other intangible assets, net | 742,221 | 752,088 | ||||||
Other non-current assets | 188,796 | (a) | 103,373 | |||||
Total assets | $ | 2,789,321 | $ | 2,618,847 | ||||
Short-term borrowings and maturities of long-term debt | $ | 55,868 | $ | 49,670 | ||||
Trade accounts payable | 185,592 | 196,641 | ||||||
Accrued and other current liabilities | 513,052 | (a) | 488,123 | |||||
Total current liabilities | 754,512 | 734,434 | ||||||
Long-term debt | 1,235,350 | 985,021 | ||||||
Other non-current liabilities | 378,679 | (a) | 309,329 | |||||
Total liabilities | 2,368,541 | 2,028,784 | ||||||
Shareholders’ equity | 420,780 | 590,063 | ||||||
Total liabilities and shareholders’ equity | $ | 2,789,321 | $ | 2,618,847 | ||||
(a) | Includes a lease right-of-use asset of $87.3 million, a short-term lease liability of $27.6 million and a long-term lease liability of $60.9 million in accordance with ASC 842 "Leases" that went into effect on January 1, 2019. |
METTLER-TOLEDO INTERNATIONAL INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (amounts in thousands) (unaudited) | ||||||||||||||||
Three months ended | Twelve months ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
Cash flow from operating activities: | ||||||||||||||||
Net earnings | $ | 192,749 | $ | 181,186 | $ | 561,109 | $ | 512,611 | ||||||||
Adjustments to reconcile net earnings to | ||||||||||||||||
net cash provided by operating activities: | ||||||||||||||||
Depreciation | 9,643 | 9,278 | 38,991 | 37,167 | ||||||||||||
Amortization | 12,813 | 11,963 | 49,690 | 47,524 | ||||||||||||
Deferred tax expense | 29,166 | 14,203 | 11,203 | 2,302 | ||||||||||||
Share-based compensation | 5,002 | 5,074 | 18,285 | 17,579 | ||||||||||||
Swiss tax reform benefit (a) | (15,833 | ) | — | (15,833 | ) | — | ||||||||||
U.S. tax reform charge (b) | — | 3,597 | — | 3,597 | ||||||||||||
Acquisition gain (c) | — | (18,674 | ) | — | (18,674 | ) | ||||||||||
Other | 161 | 147 | 133 | (2,559 | ) | |||||||||||
Decrease in cash resulting from changes in | ||||||||||||||||
operating assets and liabilities | (31,992 | ) | (8,202 | ) | (60,128 | ) | (34,542 | ) | ||||||||
Net cash provided by operating activities | 201,709 | 198,572 | 603,450 | 565,005 | ||||||||||||
Cash flows from investing activities: | ||||||||||||||||
Proceeds from sale of property, plant and equipment | 174 | 381 | 1,422 | 8,190 | ||||||||||||
Purchase of property, plant and equipment | (25,714 | ) | (46,061 | ) | (97,341 | ) | (142,726 | ) | ||||||||
Acquisitions | — | (565 | ) | (2,004 | ) | (5,527 | ) | |||||||||
Net hedging settlements on intercompany loans | 2,939 | 1,899 | (1,160 | ) | 1,119 | |||||||||||
Net cash used in investing activities | (22,601 | ) | (44,346 | ) | (99,083 | ) | (138,944 | ) | ||||||||
Cash flows from financing activities: | ||||||||||||||||
Proceeds from borrowings | 627,370 | 168,341 | 1,435,081 | 940,615 | ||||||||||||
Repayments of borrowings | (515,989 | ) | (172,620 | ) | (1,176,784 | ) | (876,324 | ) | ||||||||
Proceeds from exercise of stock options | 9,665 | 9,823 | 47,581 | 24,600 | ||||||||||||
Repurchases of common stock | (216,249 | ) | (118,750 | ) | (774,999 | ) | (474,999 | ) | ||||||||
Acquisition contingent consideration payment | — | — | (10,000 | ) | — | |||||||||||
Other financing activities | — | (250 | ) | 1,753 | (1,914 | ) | ||||||||||
Net cash used in financing activities | (95,203 | ) | (113,456 | ) | (477,368 | ) | (388,022 | ) | ||||||||
Effect of exchange rate changes on cash and cash equivalents | 3,348 | (108 | ) | 2,676 | (8,616 | ) | ||||||||||
Net increase in cash and cash equivalents | 87,253 | 40,662 | 29,675 | 29,423 | ||||||||||||
Cash and cash equivalents: | ||||||||||||||||
Beginning of period | 120,534 | 137,448 | 178,110 | 148,687 | ||||||||||||
End of period | $ | 207,787 | $ | 178,110 | $ | 207,785 | $ | 178,110 | ||||||||
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW | ||||||||||||||||
Net cash provided by operating activities | $ | 201,709 | $ | 198,572 | $ | 603,450 | $ | 565,005 | ||||||||
Payments in respect of restructuring activities | 7,033 | 4,119 | 16,483 | 20,820 | ||||||||||||
Proceeds from sale of property, plant and equipment | 174 | 381 | 1,422 | 8,190 | ||||||||||||
Purchase pf property, plant and equipment | (25,714 | ) | (46,061 | ) | (97,341 | ) | (142,726 | ) | ||||||||
Payments for one-time legal charge (d) | 2,992 | — | 2,992 | — | ||||||||||||
Transition tax payment | — | — | 4,289 | 4,200 | ||||||||||||
Payments for acquisition costs | — | 233 | — | 375 | ||||||||||||
Adjusted free cash flow | $ | 186,194 | $ | 157,244 | $ | 531,295 | $ | 455,864 | ||||||||
(a) | Represents a non-cash deferred net benefit of $15.8 million for the three and twelve months ended December 31, 2019 related to the enactment of Swiss tax reform. | |||||||||||||||
(b) | Represents U.S. tax reform charge of $3.6 million for the three and twelve months ended December 31, 2018 for the implementation of the Tax Cuts and Jobs Act. | |||||||||||||||
(c) | Represents a one-time gain of $18.7 million relating to the Biotix acquisition contingent consideration for the three and twelve months ended December 31, 2018. | |||||||||||||||
(d) | Represents cash payments related to the one-time legal charge recorded during the three months ended December 31, 2018. |
METTLER-TOLEDO INTERNATIONAL INC. OTHER OPERATING STATISTICS | ||||||||||||||||||||
SALES GROWTH BY DESTINATION | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Europe | Americas | Asia/RoW | Total | |||||||||||||||||
U.S. Dollar Sales Growth (Decrease) | ||||||||||||||||||||
Three Months Ended December 31, 2019 | (1%) | 6% | 4% | 3% | ||||||||||||||||
Twelve Months Ended December 31, 2019 | (2%) | 5% | 3% | 2% | ||||||||||||||||
Local Currency Sales Growth (Decrease) | ||||||||||||||||||||
Three Months Ended December 31, 2019 | 1% | 6% | 5% | 4% | ||||||||||||||||
Twelve Months Ended December 31, 2019 | 3% | 6% | 6% | 5% | ||||||||||||||||
RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three months ended | Twelve months ended | |||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||
2019 | 2018 | % Growth | 2019 | 2018 | % Growth | |||||||||||||||
EPS as reported, diluted | $ | 7.84 | $ | 7.11 | 10% | $ | 22.47 | $ | 19.88 | 13% | ||||||||||
Restructuring charges, net of tax | 0.15 | (a) | 0.14 | (a) | 0.50 | (a) | 0.56 | (a) | ||||||||||||
Purchased intangible amortization, net of tax | 0.11 | (b) | 0.10 | (b) | 0.43 | (b) | 0.39 | (b) | ||||||||||||
Income tax expense | 0.32 | (c) | 0.02 | (c) | — | — | ||||||||||||||
Swiss Tax reform | (0.64 | ) | (d) | — | (0.63 | ) | (d) | — | ||||||||||||
U.S. Tax reform | — | 0.14 | (e) | — | 0.14 | (e) | ||||||||||||||
Acquisition gain, net of tax | — | (0.75 | ) | (f) | — | (0.74 | ) | (f) | ||||||||||||
Legal charge, net of tax | — | 0.09 | (g) | — | 0.09 | (g) | ||||||||||||||
Adjusted EPS, diluted | $ | 7.78 | $ | 6.85 | 14% | $ | 22.77 | $ | 20.32 | 12% | ||||||||||
Notes: | ||||||||||||||||||||
(a) | Represents the EPS impact of restructuring charges of $4.6 million ($3.7 million after tax) and $4.5 million ($3.5 million after tax) for the three months ended December 31, 2019 and 2018, and $15.8 million ($12.6 million after tax) and $18.4 million ($14.5 million after tax) for the twelve months ended December 31, 2019 and 2018, respectively, which primarily include employee related costs. | |||||||||||||||||||
(b) | Represents the EPS impact of purchased intangibles amortization, net of tax, of $3.8 million ($2.8 million after tax) and $3.3 million ($2.5 million after tax) for the three months ended December 31, 2019 and 2018, and $14.3 million ($10.8 million after tax) and $13.3 million ($10.0 million after tax) for the twelve months ended December 31, 2019 and 2018, respectively. | |||||||||||||||||||
(c) | Represents the EPS impact of the difference between our reported and annual tax rate before non-recurring discrete items, due to the timing of excess tax benefits associated with stock option exercises. | |||||||||||||||||||
(d) | Represents the EPS impact of a non-cash deferred net benefit of $15.8 million related to the enactment of Swiss tax reform for the three and twelve months ended December 31, 2019. | |||||||||||||||||||
(e) | Represents the EPS impact of U.S. tax reform charges of $3.6 million for the three and twelve months ended December 31, 2018, related to the implementation of the Tax Cuts and Jobs Act. | |||||||||||||||||||
(f) | Represents the EPS impact of a one-time gain of $18.7 million ($19.2 million after tax) for the three and twelve months ended December 31, 2018 associated with the Biotix acquisition contingent consideration. | |||||||||||||||||||
(g) | Represents the EPS impact of a one-time legal charge of $3.0 million ($2.4 million after tax) for the three and twelve months ended December 31, 2018. |